Avistone Pharmaceuticals procures over $200m
Avistone Pharmaceuticals, a clinical-stage biotechnology company focused on precision oncology therapeutics, has raised over $200 million in funding.
Avistone Pharmaceuticals, a clinical-stage biotechnology company focused on precision oncology therapeutics, has raised over $200 million in funding.
Copyright PEI Media
Not for publication, email or dissemination